Jeremias F, Roberto DC, Sgavioli MEM

Idioma: Español
Referencias bibliográficas: 39
Paginas: 162-171
Archivo PDF: 192.64 Kb.

RESUMEN

El término penfigoide de membranas mucosas designa un grupo de enfermedades vesículo-bulosas autoinmunes crónicas, que afectan predominantemente mucosas. El presente artículo describe dos casos clínicos de penfigoide de membranas mucosas con compromiso gingival y tuvo como objetivo resaltar la importancia de un correcto diagnóstico de la lesión y discutir la conducta terapéutica. Fueron realizados diversos exámenes complementares como, examen de Nikolsky, biopsia incisional, investigación de células LE y de anticuerpos antinucleares, además de la evaluación de médicos especializados en dermatología y oftalmología. Fue fundamental la substitución de dentífricos, la orientación nutricional y psicológica, el cuidado con la higiene, además del uso de corticoides tópicos. Hubo periodos de remisión y exacerbación del cuadro clínico durante el seguimiento, fue necesario el ajuste en la terapéutica y refuerzo en los cuidados con la higiene bucal. Es muy importante la interacción multidisciplinaria en la atención de estos casos para el control del tratamiento y seguimiento, además de reforzar todas las orientaciones y cuidados en lo que se refiere a la salud bucal y cautela en el uso de corticoides.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370-9.

2. Dabelsteen E. Molecular biological aspects of acquired bullous diseases. Crit Rev Oral Biol Med. 1998;9:162-78.

3. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoid: a heterogenous immunomediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:56-68.

4. Dayan S, Simmons RK, Ahmed AR. Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:424-30.

5. Robinson NA, Wray D. Desquamative gingivitis: a sign of mucocutaneous disorders-a review. Austr Dent J. 2003;48(4):206-11.

6. Arisawa EAL, Almeida JD, Carvalho YR, Cabral LAG. Clinicopathological analysis of oral mucous autoimmune disease: A 27-year study. Med Oral Patol Oral Cir Bucal. 2008;13:94-7.

7. Moschella SM, Pillsbury DM, Jr Hurley HJ. Dermatology. Philadelphia: WB Saunders; 1975.

8. González-Moles MA, Morales García P, Rodríguez Archilla A. Clobetasol mouthwash is effective for severe oral erosive lesions (abstract). Dent Abstr. 2002; 47:268.

9. González-Moles MA, Morales García P, Rodríguez Archilla A, Ruiz-Ávila I, González Moles S. Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:264-70.

10. González-Moles MA, Morales García P, Rodríguez Archilla A, Ruiz Ávila I, Mesa Aguado F, Bascones Martínez A, et al. Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:688-92.

11. González-Moles M, Scully A, Scully C. Vesiculo-erosive oral mucosal diseasemanagement with topical corticosteroids: (1) Fundamental principles and specific agents available. J Dent Res. 2005;84:294-301.

12. Alkan A, Gunhan O, Alkan A, Otan F. A clinical study of oral mucous membrane pemphigoid. J Int Med Res. 2003;31:340-44.

13. Chan LS, Soong HK, Foster CS, Hammerberg C, Cooper KD. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome. JAMA. 1991;266:1543-6.

14. Vassileva S. Drug-induced pemphigoid: bullous and cicatricial. Clin Dermatol. 1998;16:379-87.

15. Fiore PM, Jacobs IH, Goldberg DR. Drug-induced pemphigoid. Arch Ophthalmol. 1987;105:1660-3.

16. Challocombe SJ, Setterfield J, Shirlaw P, Harman K, Scully C, Black MM. Immunodiagnosis of pemphigus and mucous membrane pemphigoid. Acta Odontol Scand. 2001;59:226-34.

17. Shklar G. Desquamative gingivitis and oral mucous membrane diseases. In: Carranza FA, Newman GM. eds. Clinical Periodontology. Philadelphia: WB Saunders; 1996. v8. p. 259-75.

18. Armitage GC. Developmental of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1-6.

19. Scully C, Laskaris G. Mucocutaneous disorders. Periodontol 2000. 1998;18:81-94.

20. Yih WT, Maier T, Kratochvil FJ, Zieper MB. Analysis of desquamative gingivitis using direct immunofluorescence in conjunction with histology. J Periodontol. 1998;69:678-85.

21. Sollecito TP, Greenberg MS. Plasma cell gingivitis. Report of two cases. Oral Surg Oral Med Oral Pathol. 1992;73:690-3.

22. Staines KS, Felix DH, Forsyth A. Desquamative gingivitis, sole manifestation of tosylamide/formaldehyde resin allergy. Contact Dermatitis. 1998;39:90.

23. Scully C, Porter SR. The clinical spectrum of desquamative gingivitis. Semin Cutan Med Surg. 1997;16:308-13.

24. Vaillant L, Chauchaix-Barthes S, Huttenberger B, Arbeille B, Machet M, Jan V, et al. Chronic desquamative gingivitis syndrome: Retrospective analysis of 33 cases in French. Ann Dermatol Venereol. 2000;127:381-7.

25. Tricamo MB, Rees TD, Hallmon WW, Wright JM, Cueva MA, Plemons JM. Periodontal status in patients with gingival mucous membrane pemphigoid. J Periodontol. 2006;77:398-405.

26. Ramon-Fluixa C, Bagan-Sebastian J, Milian-Masanet M, Scully C. Periodontal status in patients with oral lichen planus. A study of 90 cases. Oral Dis. 1999;5:303-6.

27. American Academy of Periodontology. Oral features of mucocutaneous disorders (position paper). J Periodontol. 2003;74:1545-56.

28. Yancey KB, Egana CA. Pemphigoid: clinical, histologic, imunopathologic and therapeutic considerations. JAMA. 2000;284:350-6.

29. Rogers RS, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol. 1986;6:215-23.

30. Poskitt L, Wojnarowska F. Minimizing cicatricial pemphigoid orodynia with minocycline. Br J Dermatol. 1995;132:784-9.

31. Vincent SD, Baker KA, Williams TP. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1990;70:165-71.

32. Lozada-Nur F, Huang MZ, Zhou G. Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1991;71:283-7.

33. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05 % clobetasol propionate ointment in orabase and 0.05 % fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1994;77:598-604.

34. Lozada-Nur F, Robinson J, Regezi JA. Oral hairy leukoplakia in nonimmunosuppressed patients: report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1994;78:599-602.

35. Lozada-Nur F, Miranda C. Oral lichen planus: topical and systemic therapy. Sem Cutan Med Surg. 1997;16:295-300.

36. Lo Muzio L, Della Valle A, Mignogna MD, Pannone G, Bucci P, Bucci E. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med. 2001;30:611-7.

37. Ronbeck BA, Lind PO, Thrane S. Desquamative gingivitis: preliminary observations with tetracycline treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1990;69:694-7.

38. Allenby CF, Main RA, Marsden RA, Sparkes CG. Effect on adrenal function of topically applied clobetasol propionate (Dermobate). Br Med J. 1975;4:619-21.

39. Carbone M, Conrott D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Disease. 1999;5:44-9.